A Sense of Déjà Vu: The Debate Surrounding State Biosimilar Substitution Laws

Source: http://www.aarp.org/health/health-insurance/info-2014/the-debate-surrounding-state-biosimilar-laws-AARP-ppi-health.html

The Affordable Care Act created an approval pathway for less expensive generic versions of biologic drugs, known as biosimilars, or follow-on biologics….

Source: http://www.aarp.org/health/health-insurance/info-2014/the-debate-surrounding-state-biosimilar-laws-AARP-ppi-health.html

The Affordable Care Act created an approval pathway for less expensive generic versions of biologic drugs, known as biosimilars, or follow-on biologics….

What Do You Think?

comments

Translate »